Mortality and Metformin
The discussion centers around the Kaplan Meyer curve, a vital tool for understanding mortality rates. It highlights the stark difference in survival between individuals with type 2 diabetes on metformin and their matched controls, revealing that those on metformin are dying at a faster rate. This analysis emphasizes the importance of scrutinizing treatment outcomes, as the curves illustrate a consistent downward trend for diabetics on metformin, contrasting sharply with non-diabetic controls.In this clip
From this podcast
Huberman Lab
Journal Club with Dr. Peter Attia | Metformin for Longevity & The Power of Belief Effects
Related Questions